SCLX Q2 2025 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q2 2025 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$10M-39.5% YoY

Gross Profit

$7M66.9% margin

Operating Income

-$21M-207.2% margin

Net Income

-$86M-869.7% margin

EPS (Diluted)

$-7.42

QoQ Revenue Growth

+97.8%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$84M

Total Liabilities

$333M

Stockholders' Equity

-$249M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$16M	-39.5%
Gross Profit	$7M	$12M	-44.7%
Operating Income	-$21M	-$16M	-31.3%
Net Income	-$86M	-$38M	-129.0%